Sponsor Pipeline

Shenzhen Ionova Life Sciences Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
7
Disease Areas
Active Trials by Phase
Phase 1/2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07612891 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor… Breast Cancer (Locally Advanced or Metastatic) Recruiting
NCT06609005 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor… Advanced Metastatic Castration Resistant Prostate Cancer Recruiting
NCT07610798 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor… Advance Solid Tumors Recruiting
Phase 1
NCT04443088 An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab… Cancer Recruiting
Disease Areas
Get alerts when Shenzhen Ionova Life Sciences Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free